REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea · Delayed Price · Currency is KRW
11,930
+530 (4.65%)
At close: Feb 20, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2012 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '12 Dec 31, 2012 |
|---|
| 148.30B | 151.07B | 154.04B | 142.80B | 130.03B | | | | | |
| -1.83% | -1.93% | 7.87% | 9.82% | - | | | | | |
| 148.30B | 151.07B | 154.04B | 142.80B | 130.03B | | | | | |
| -1.83% | -1.93% | 7.87% | 9.82% | -1.16% | | | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2012 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '12 Dec 31, 2012 |
|---|
| 77.33M | - | - | - | - | | | | | |
| 33.69M | 75.42M | - | - | 3.76M | | | | | |
| -55.32% | - | - | - | -70.44% | | | | | |
| 368.76M | 446.77M | 323.36M | - | 65.05M | | | | | |
| -17.46% | 38.17% | - | - | -59.40% | | | | | |
| 33.36M | 32.70M | - | - | - | | | | | |
| 2.04% | - | - | - | - | | | | | |
| 88.70M | 60.96M | 31.69M | 47.42M | 44.13M | | | | | |
| 45.51% | 92.36% | -33.17% | 7.45% | 86.09% | | | | | |
| 146.65B | 149.52B | 151.67B | 140.89B | 128.02B | | | | | |
| -1.92% | -1.42% | 7.65% | 10.05% | 0.26% | | | | | |
| 902.88M | 831.00M | 1.79B | 1.78B | 1.85B | | | | | |
| 8.65% | -53.46% | 0.51% | -3.95% | 2.42% | | | | | |
| - | - | 18.33M | 5.57M | - | | | | | |
| - | - | 228.87% | - | - | | | | | |
| - | - | - | 8.95M | - | | | | | |
| 84.47M | 89.26M | - | 69.28M | 46.78M | | | | | |
| -5.36% | - | - | 48.09% | -64.21% | | | | | |
| 56.12M | 17.14M | 17.60M | - | - | | | | | |
| 227.44% | -2.63% | - | - | - | | | | | |
| - | - | 197.06M | - | - | | | | | |
| 148.30B | 151.07B | 154.04B | 142.80B | 130.03B | | | | | |
| -1.83% | -1.93% | 7.87% | 9.82% | -1.16% | | | | | |
Source: S&P Global Market Intelligence.